New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
09:31 EDTMJNMead Johnson downgraded to Hold from Buy at Miller Tabak
News For MJN From The Last 14 Days
Check below for free stories on MJN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
14:25 EDTMJNMead Johnson calls active after WSJ says Danone seeking expansion
Subscribe for More Information
14:23 EDTMJNMead Johnson jumps after WSJ says Danone started strategic review
Shares of Mead Johnson (MJN) are moving higher after the Wall Street Journal reported that Danone (DANOY) has launched a strategic review. The French company has asked its top managers to explore expansion opportunities, The Journal stated, citing a person familiar with the matter. Shares of Mead Johnson, which reported its Q2 earnings earlier today, spiked 5%, or $4.91, to $97.18 following the report. WhiteWave Foods (WWAV) also moved higher following the report.
14:15 EDTMJNMead Johnson spikes after WSJ says Danone seeking expansion opportunities
14:14 EDTMJNMead Johnson rallies to high of the day, up 6% to $98.10
Subscribe for More Information
07:32 EDTMJNMead Johnson sees FY14 EPS $3.65-$3.72, consensus $3.70
Subscribe for More Information
07:31 EDTMJNMead Johnson reports Q2 adjusted EPS 88c consensus 89c
Subscribe for More Information
July 18, 2014
07:40 EDTMJNMead Johnson August volatility elevated as shares near record high into Q2
Subscribe for More Information
06:17 EDTMJNMead Johnson risk/reward favorable into Q2 results, says Citigroup
Subscribe for More Information
July 15, 2014
10:00 EDTMJNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:46 EDTMJNMead Johnson upgraded to Buy from Neutral at Goldman
Goldman Sachs upgraded Mead Johnson to Buy saying the company's results should beat expectations while it remains an attractive takeover candidate. Goldman raised its price target for shares to $107 from $91.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use